Editor's Note: Dasatinib Plus Nutlin-3 Shows Synergistic Antileukemic Activity in Both p53wild-type and p53mutated B Chronic Lymphocytic Leukemias by Inhibiting the Akt Pathway.

Details

Language :

English

ISSN :

1557-3265

Volume :

28

Issue :

13

Database :

MEDLINE

Journal :

Clinical cancer research : an official journal of the American Association for Cancer Research

Accession number :

35775191

Full Text :

https://doi.org/10.1158/1078-0432.CCR-22-1596